Prescription drug · ANDA
Leucovorin Calcium NDC 71205-908
Leucovorin calcium 5 mg/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-908-00 | 71205090800 | 100 TABLET in 1 BOTTLE (71205-908-00)Marketed from Jul 16, 2021 | |
| 71205-908-11 | 71205090811 | 1000 TABLET in 1 BOTTLE (71205-908-11)Marketed from Jul 16, 2021 | |
| 71205-908-30 | 71205090830 | 30 TABLET in 1 BOTTLE (71205-908-30)Marketed from Jul 16, 2021 | |
| 71205-908-55 | 71205090855 | 500 TABLET in 1 BOTTLE (71205-908-55)Marketed from Jul 16, 2021 | |
| 71205-908-60 | 71205090860 | 60 TABLET in 1 BOTTLE (71205-908-60)Marketed from Jul 16, 2021 | |
| 71205-908-90 | 71205090890 | 90 TABLET in 1 BOTTLE (71205-908-90)Marketed from Jul 16, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Leucovorin Calcium
- Generic name (nonproprietary)
- leucovorin calcium
- Active ingredients
- Leucovorin calcium — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213929
- Marketing start
- Listing expires
- Other FDA classes
- Folic Acid (Chemical structure)
- Identifiers
- Product ID 71205-908_349c3831-62bc-4f66-9c19-5185520af6c6SPL ID 349c3831-62bc-4f66-9c19-5185520af6c6SPL set ID 46d12bd0-ec7d-4e2c-aeed-b8aa88e6dc5cRxCUI 197863UNII RPR1R4C0P4UPC 0371205908300
- Pharmacologic class
- Folate Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205090800followed by a unit qualifier and the quantityPackage 71205-0908-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Leucovorin Calcium Tablets are indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 213929
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Leucovorin Calcium | Leucovorin calcium 10 mg/1 | TabletOral | Leading Pharma, LLC | 69315-185 |
| Leucovorin Calcium | Leucovorin calcium 5 mg/1 | TabletOral | Leading Pharma, LLC | 69315-184 |
| Leucovorin Calcium | Leucovorin calcium 15 mg/1 | TabletOral | Leading Pharma, LLC | 69315-186 |
| Leucovorin Calcium | Leucovorin calcium 25 mg/1 | TabletOral | Leading Pharma, LLC | 69315-187 |